O cancao do colon, conosciuo ascì comme cancao colorettale, o l'é unna mouttia seria e potenzialmente mortale.
O l'é o terso cancao ciù commun inti Stati Unii e a segonda caxon de mòrte pe cancao.
O tascio generale de sopravivensa à 5 anni pe-o cancao do colon o l"é de ciù ò meno o 65%, ma sto chì o cangia à segonda do stadio into quæ o cancao o l"é stæto diagnosticou.
Se o cancao o vëgne descoverto a-o prinçipio, o tascio de sopravivensa à 5 anni o peu ëse fin à 90%, ma se o cancao o s'é spantegou inte atre parte do còrpo, o tascio de sopravivensa o s'abbassa à çirca o 111%.
L"é importante notâ che i tasci de sopravivensa en solo de stime e che i exiti individuali peuan variâ.
Un contròllo regolare e un trattamento pronto peuan redue de mainea significativa o reisego che o cancao do colon o divente de grammo fâ.
Andersen LD, Remington P, Trentham-Dietz A, Reeves M: Assessing a decade of progress in cancer control. Oncologist. 2002, 7 (3): 200-4.
Wang YG, Chen KX, Wu GL, Song FJ: An analysis: colon cancer mortality in Tianjin, China, from 1981 to 2000. World J Gastroenterol. 2005, 11 (6): 895-8.
Tsuji K, Harashima E, Nakagawa Y, Urata G, Shirataka M: Time-lag effect of dietary fiber and fat intake ratio on Japanese colon cancer mortality. Biomed Environ Sci. 1996, 9 (2-3): 223-8.
Kanter MH, Schottinger JE, Joshua A, Slezak JM: Beyond Screening: An Interim Report and Analysis of a Multimodal Initiative to Decrease Colon Cancer Mortality. Jt Comm J Qual Patient Saf. 2022, 48 (8): 388-394.
Tseng CH: Diabetes but not insulin is associated with higher colon cancer mortality. World J Gastroenterol. 2012, 18 (31): 4182-90.
Jacobs EJ, Connell CJ, Patel AV, Chao A, Rodriguez C, Seymour J, McCullough ML, Calle EE, Thun MJ: Multivitamin use and colon cancer mortality in the Cancer Prevention Study II cohort (United States). Cancer Causes Control. 2001, 12 (10): 927-34.
['Disclaimer: medicâ']
["Sto scito web o l'é fornio solo pe di propòxiti educativi e informativi e o no costituisce un conseggio medico ò serviççi profescionæ."]
["L'informaçion fornia a no dovieiva ëse deuviâ pe diagnosticâ ò curâ un problema de sanitæ ò unna mouttia, e quelli che çercan un conseggio medico personale devan consultâ un mego licençiou."]
['Pe piaxei, ti ti o sæ che a ræ neurale ch\'a genera de respòste a-e domande a l"é inprecisa sorviatutto quande se tratta de contegnui numerichi, comme o numero de persoñe che gh\'é stæto diagnosticou unna mouttia particolâ.']
["çercâ delongo o conseggio do teu mego ò de un atro fornitô de sanitæ qualificou in sciâ condiçion medica. no trascurâ mai o conseggio de un mego profescionista ò ritardâ a çercâlo apreuvo à quarcösa che ti t'æ lezuo in sce sto scito web."]
['Disclaimer: copyright']
["O Digital Millennium Copyright Act do 1998, 17 U.S.C. § 512 (o DMCA) o fornisce un ricorso pe-i propietäi de copyright che creddan che o materiale ch'o l'appare in sce Internet o l'infrange i seu driti segondo a leze di copyright di Stati Unii. "]
["Se ti ti creddi de bonn-a fede che un qualunque contegnûo ò materiale misso a dispoxiçion in connescion co-o nòstro scito web ò serviççi o l'infrange i teu driti d'autô, ti (ò o teu agente) ti peu mandâne 'na notifica con domandâ che o contegnûo ò o materiale o segge levòu ò che l'acesso o segge bloccou."]
['E comunicaçioin devan vegnî mandæ pe iscritto pe email (veddi a seçion "Contact" pe l\'indirissô email).']
["O DMCA o l'exige che a teu notifica de presunta violaçion di driti d'autô a contégne e informaçioìn chi sótta: (1) descriçion de l'euvia protetta da driti d'autô ch'a l'é l'oggetto da presunta violaçion; (2) descriçion do contegnûo che se presumibilmente o l'é a violaçion e informaçioìn suffiçienti pe permette a niatri de localizzâlo; (3) informaçioìn de contatto pe ti, compreiso o teu indirìsso, o teu nómme de telefonin e o teu indirìsso email; (4) 'na teu affermaçion che ti ti credi de bonn-a fêde che o contegnûo into mòddo reclamòu o no segge autorizòu da-o propietâio di driti d'autô, ò da-o seu agente, ò da l'açion de quæ se segge leze; "]
["(5) unna declaraçion da parte teu, firmâ sotta pena de perjurio, che e informaçioin inta notifica son accuræ e che ti gh'æ l'autoritæ de fâ respettâ i driti d'autô che se sostegne che seggian stæti violati;"]
["e (6) unna firma fixica ò elettrònica do propietäio do drito d'autô ò de unna persoña autorisâ à agî a-o seu nomme."]
["Se no ti inserisci tutte e informaçioin chì de d'ato, o peu comportâ un retardo into trattamento da teu lamentela."]
['Contatto']
["Pe piaxei manda 'na mail con ògni domanda/suggerimento."]
How deadly is colon cancer?
Colon cancer, also known as colorectal cancer, is a serious and potentially deadly disease.
It is the third most common cancer in the United States and the second leading cause of cancer deaths.
The overall 5-year survival rate for colon cancer is approximately 65%, but this varies depending on the stage at which the cancer is diagnosed.
If caught early, the 5-year survival rate can be as high as 90%, but if the cancer has spread to other parts of the body, the survival rate drops to around 111%. Early detection and treatment are crucial for improving the chances of survival.
It is important to note that survival rates are only estimates and individual outcomes may vary.
Regular screening and prompt treatment can significantly reduce the risk of colon cancer becoming deadly.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['In sciâ']
['BioMedLib o deuvia di computer automatizzæ (algoritmi de machine learning) pe generâ de cobbie de domande e respòste.']
['Comensemmo con 35 mioin de pubricaçioin biomediche de PubMed/Medline.']
